6-158191990-A-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_207118.3(GTF2H5):c.49A>T(p.Lys17*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_207118.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461586Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 727122
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Trichothiodystrophy 3, photosensitive Pathogenic:1
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Lys17*) in the GTF2H5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 55 amino acid(s) of the GTF2H5 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with trichothiodystrophy (PMID: 30359777). ClinVar contains an entry for this variant (Variation ID: 975159). This variant disrupts a region of the GTF2H5 protein in which other variant(s) (p.Arg56*) have been determined to be pathogenic (PMID: 15220921, 25620205). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at